← Back to KURA

Kura Oncology, Inc. - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 12/08/2026Mar 2026Filed 12/08/2026Sep 2025Filed 04/11/2025Jun 2025Filed 12/08/2026Mar 2025Filed 12/08/2026Sep 2024Filed 04/11/2025Jun 2024Filed 04/11/2025Mar 2024Filed 04/11/2025
$21$18$21$15$14
−$68−$73−$74−$66−$57−$54−$51−$50
−$0.77−$0.83−$0.85−$0.75−$0.66−$0.63−$0.59−$0.59
8989888887878784

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.